Can Pfizer Bank on Fresh Immunotherapy Bavencio for Growth? August 17, 2017
Can Pfizer Bank on Fresh Immunotherapy Bavencio for Growth? Zacks Equity Research August 17, two thousand seventeen As request for immuno-oncology drugs and their combinations rises, Pfizer, Inc.`s ( PFE – Free Report) freshly approved immunotherapy, Bavencio, is being considered a significant top-line driver for this Fresh York-based pharma giant.